Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Agilent, MDS Proteomics to Collaborate on Protein Analysis Technology

NEW YORK, May 22 – Signaling its effort to expand into the burgeoning proteomics arena, Agilent Technologies said Tuesday it has agreed to partner with MDS Proteomics to develop laboratory technology for identifying and analyzing proteins more quickly. 

The joint effort will draw on Agilent’s expertise in separation science and liquid chromatography, and MDS Proteomics’ experience in mass spectrometry, bioinformatics, and the study of protein pathways.

“Right now getting [separations] technology configured for proteomics has tremendous benefit for our customers, “ said Doug Forsyth, a spokesman for Agilent. 

Forsyth said Agilent and MDS will combine existing technology such as liquid chromatography and mass spectrometry with bioinformatics solutions specifically tailored for proteomics to boost the throughput of protein analysis.

“Together we’ll identify bottlenecks, problems,” said Forsyth. “Agilent will come up with the equipment, and MDS will provide certain components” such as bioinformatics expertise.

From the collaboration, the two companies hope to sell equipment and laboratory technology to pharmaceutical, biotechnology, and other companies in engaged in proteomics research. Further financial details of the collaboration were not disclosed.  
The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.